EUVIMEDEUVIMED entdecken
Crossref

3,5-Dicaffeoylquinic acid attenuates poststroke muscle atrophy through GPX4 dependent ferroptosis inhibition

Hu Qi, Zeyang Zhang, Yuanlin Gao, Dan Tian, Qiyue Peng, Xiongwei Zhang, Shanshan Ou, Hao Wang, Jiuseng Zeng, Aotao Zhao, Rong Liu, Ruocong Yang und 1 weitere

Phytomedicine · 2026-09 · 159 · 158563

DOI: 10.1016/j.phymed.2026.158563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Hu Qi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lab for Innovation & Effective Uses of Chinese Drug Germplasm Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; S…. Hauptthemen laut MEDLINE: Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Muscular Atrophy, Quinic Acid. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Ischemic stroke-induced sarcopenia (ISS) is a major contributor to poststroke motor dysfunction and severely impairs quality of life. Ferroptosis, an iron- and lipid peroxidation- dependent form of programmed cell death, has not been fully explored in ISS. PURPOSE To evaluate the natural compound 3,5-dicaffeoylquinic acid (3,5-DCQA) as a novel anti-ferroptosis agent that markedly attenuates ISS via glutathione peroxidase 4 (GPX4)-mediated ferroptosis inhibition. METHODS A permanent middle cerebral artery occlusion (pMCAO) rat model was established. Cerebral injury was assessed using laser speckle contrast imaging and Zea-Longa neurological scoring. The effect of 3,5-DCQA on muscle function was evaluated through behavioral analyses and histopathological staining. Molecular interactions were validated by combining GPX4 silencing via siRNA in L6 cells with RNA-seq and surface plasmon resonance (SPR). The involvement of the ferroptosis signaling pathway in ISS was examined using flow cytometry, immunofluorescence (IF), immunohistochemistry (IHC), and Western blotting (WB). RESULTS 3,5-DCQA markedly improved muscle mass, strength, and motor performance. Mechanistically, it reduced ferrous iron and lipid peroxidation products, including malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and lipid peroxides, and downregulated muscle atrophy factors, muscle RING-finger protein-1 (MuRF1) and muscle atrophy F-box (MAFbx). In vitro, 3,5-DCQA decreased reactive oxygen species (ROS) and ferrous iron accumulation, inhibited acyl-CoA synthetase long-chain family member 4 (ACSL4), and restored GPX4 signaling and intracellular GSH, thereby alleviating erastin-induced ferroptosis in L6 myoblasts. Molecular docking and molecular dynamics simulations supported a stable interaction between 3,5-DCQA and GPX4, which was further confirmed by SPR with a KD value of 3.92 × 10-⁶ M. Moreover, 3,5-DCQA weakly bound to MuRF1. These findings confirm GPX4 as the key mediator, as GPX4 knockdown abolished its effects on ferroptosis, oxidative stress, and myogenic recovery. CONCLUSIONS 3,5-DCQA mitigates poststroke muscle atrophy through GPX4-dependent ferroptosis suppression and redox restoration, supporting its therapeutic potential in ISS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPhospholipid Hydroperoxide Glutathione PeroxidaseMuscular AtrophyQuinic AcidStrokeAnimalsMaleRatsRats, Sprague-DawleyOxidative StressDisease Models, AnimalLipid PeroxidationInfarction, Middle Cerebral ArteryChlorogenic Acid

Stichwörter der Autor:innen

FerroptosisGPX4Ischemic stroke, 3,5-DCQAMuscle atrophySarcopenia

Substanzen

Phospholipid Hydroperoxide Glutathione Peroxidaseglutathione peroxidase 4, ratQuinic Acid3,5-dicaffeoylquinic acidChlorogenic Acid

Autor:innen und Institutionen

  • Lab for Innovation & Effective Uses of Chinese Drug Germplasm Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine,…
  • Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 611137, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qi, H., Zhang, Z., Gao, Y., Tian, D., Peng, Q., Zhang, X., Ou, S., Wang, H., Zeng, J., Zhao, A., Liu, R., Yang, R., & Zeng, N. (2026). 3,5-Dicaffeoylquinic acid attenuates poststroke muscle atrophy through GPX4 dependent ferroptosis inhibition. Phytomedicine, 159, 158563. https://doi.org/10.1016/j.phymed.2026.158563

Vancouver

Qi H, Zhang Z, Gao Y, Tian D, Peng Q, Zhang X, et al. 3,5-Dicaffeoylquinic acid attenuates poststroke muscle atrophy through GPX4 dependent ferroptosis inhibition. Phytomedicine. 2026;159:158563. doi:10.1016/j.phymed.2026.158563

BibTeX
@article{Qi2026,
  author = {Qi, Hu and Zhang, Zeyang and Gao, Yuanlin and Tian, Dan and Peng, Qiyue and Zhang, Xiongwei and Ou, Shanshan and Wang, Hao and Zeng, Jiuseng and Zhao, Aotao and Liu, Rong and Yang, Ruocong and Zeng, Nan},
  title = {3,5-Dicaffeoylquinic acid attenuates poststroke muscle atrophy through GPX4 dependent ferroptosis inhibition},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158563},
  doi = {10.1016/j.phymed.2026.158563}
}
Kostenlos starten →